Table 2.
Classification | Tumor cytosol miRNAs | Body fluid miRNAs | Exosome miRNAs |
---|---|---|---|
Sources | Fresh tumor tissues or FFPE tissues | Whole blood, serum, plasma, urine, CSF, sputum, saliva, or BAL | |
Special sample process for miRNA isolation | None | Need to avoid protein contamination | Need to isolate exosomes |
Complexity of isolation | + | ++ | +++ |
Detection | qRT-PCR, Northern blot, NGS, microarray | ||
Invasiveness | Yes | None | None |
Main function | Diagnosis, prognosis and therapy | Early diagnosis and prognosis | Early diagnosis, prognosis and drug transportation |
FFPE, formalin-fixed paraffin embedded; CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; NGS, next generation sequence.